Susquehanna International Group’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $950K | Buy |
211,200
+19,000
| +10% | +$83.1K | ﹤0.01% | 8004 |
|
|
2025
Q4 | $924K | Buy |
192,200
+165,800
| +628% | +$746K | ﹤0.01% | 7366 |
|
|
2025
Q3 | $120K | Buy |
26,400
+7,400
| +39% | +$27.2K | ﹤0.01% | 11452 |
|
|
2025
Q2 | $58.7K | Sell |
19,000
-122,400
| -87% | -$406K | ﹤0.01% | 12062 |
|
|
2025
Q1 | $493K | Buy |
141,400
+29,400
| +26% | +$98K | ﹤0.01% | 8930 |
|
|
2024
Q4 | $366K | Sell |
112,000
-27,000
| -19% | -$99.3K | ﹤0.01% | 9382 |
|
|
2024
Q3 | $535K | Buy |
139,000
+77,300
| +125% | +$297K | ﹤0.01% | 8294 |
|
|
2024
Q2 | $191K | Buy |
61,700
+44,700
| +263% | +$134K | ﹤0.01% | 10426 |
|
|
2024
Q1 | $43.9K | Sell |
17,000
-63,300
| -79% | -$164K | ﹤0.01% | 11606 |
|
|
2023
Q4 | $201K | Sell |
80,300
-16,300
| -17% | -$31.9K | ﹤0.01% | 10677 |
|
|
2023
Q3 | $196K | Sell |
96,600
-18,600
| -16% | -$39K | ﹤0.01% | 10251 |
|
|
2023
Q2 | $265K | Sell |
115,200
-7,300
| -6% | -$19K | ﹤0.01% | 9692 |
|
|
2023
Q1 | $371K | Sell |
122,500
-194,300
| -61% | -$548K | ﹤0.01% | 9242 |
|
|
2022
Q4 | $738K | Buy |
316,800
+46,500
| +17% | +$111K | ﹤0.01% | 6880 |
|
|
2022
Q3 | $516K | Sell |
270,300
-238,300
| -47% | -$561K | ﹤0.01% | 8401 |
|
|
2022
Q2 | $1.38M | Sell |
508,600
-398,200
| -44% | -$1.02M | ﹤0.01% | 5750 |
|
|
2022
Q1 | $2.7M | Sell |
906,800
-40,100
| -4% | -$123K | ﹤0.01% | 4820 |
|
|
2021
Q4 | $3.68M | Buy |
946,900
+134,400
| +17% | +$522K | ﹤0.01% | 4281 |
|
|
2021
Q3 | $3.49M | Buy |
812,500
+304,700
| +60% | +$1.02M | ﹤0.01% | 4634 |
|
|
2021
Q2 | $1.54M | Sell |
507,800
-16,200
| -3% | -$50.2K | ﹤0.01% | 6562 |
|
|
2021
Q1 | $1.75M | Sell |
524,000
-471,400
| -47% | -$1.82M | ﹤0.01% | 6249 |
|
|
2020
Q4 | $3.53M | Buy |
995,400
+688,000
| +224% | +$2.41M | ﹤0.01% | 4028 |
|
|
2020
Q3 | $962K | Buy |
+307,400
| New | +$935K | ﹤0.01% | 6205 |
|
|
2019
Q3 | – | Sell |
-18,200
| Closed | -$38K | – | 10079 |
|
|
2019
Q2 | $38K | Buy |
+18,200
| New | +$46.6K | ﹤0.01% | 9896 |
|
|
2019
Q1 | – | Sell |
-15,300
| Closed | -$59K | – | 8705 |
|
|
2018
Q4 | $59K | Buy |
15,300
+3,000
| +24% | +$14.8K | ﹤0.01% | 8422 |
|
|
2018
Q3 | $116K | Sell |
12,300
-6,900
| -36% | -$68.5K | ﹤0.01% | 8544 |
|
|
2018
Q2 | $140K | Sell |
19,200
-40,800
| -68% | -$243K | ﹤0.01% | 8887 |
|
|
2018
Q1 | $300K | Buy |
+60,000
| New | +$318K | ﹤0.01% | 7638 |
|
|
2017
Q4 | – | Sell |
-10,200
| Closed | -$63K | – | 9150 |
|
|
2017
Q3 | $63K | Sell |
10,200
-17,400
| -63% | -$74.4K | ﹤0.01% | 8491 |
|
|
2017
Q2 | $99K | Buy |
27,600
+1,700
| +7% | +$5.85K | ﹤0.01% | 8686 |
|
|
2017
Q1 | $84K | Sell |
25,900
-142,000
| -85% | -$394K | ﹤0.01% | 8455 |
|
|
2016
Q4 | $411K | Buy |
167,900
+96,200
| +134% | +$280K | ﹤0.01% | 7385 |
|
|
2016
Q3 | $247K | Buy |
71,700
+24,200
| +51% | +$94.5K | ﹤0.01% | 7237 |
|
|
2016
Q2 | $165K | Buy |
47,500
+34,200
| +257% | +$145K | ﹤0.01% | 7759 |
|
|
2016
Q1 | $55K | Sell |
13,300
-2,900
| -18% | -$10.4K | ﹤0.01% | 8639 |
|
|
2015
Q4 | $72K | Sell |
16,200
-27,300
| -63% | -$150K | ﹤0.01% | 8998 |
|
|
2015
Q3 | $265K | Sell |
43,500
-21,800
| -33% | -$193K | ﹤0.01% | 8237 |
|
|
2015
Q2 | $774K | Sell |
65,300
-6,700
| -9% | -$102K | ﹤0.01% | 6736 |
|
|
2015
Q1 | $1.26M | Sell |
72,000
-75,300
| -51% | -$1.54M | ﹤0.01% | 5298 |
|
|
2014
Q4 | $2.23M | Sell |
147,300
-346,300
| -70% | -$5.98M | ﹤0.01% | 4247 |
|
|
2014
Q3 | $10.4M | Buy |
493,600
+454,000
| +1,146% | +$7.41M | ﹤0.01% | 2062 |
|
|
2014
Q2 | $517K | Buy |
+39,600
| New | +$561K | ﹤0.01% | 7407 |
|
Other funds holding ABUS
TSC
WCM
VCM
RCMNY
ACM